Drugs / Pegylated IFNα-2a
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01773889 | Jun 2009 → Jun 2011 | fallopian tube carcinoma, malignant epithelial tumor of ovary, peritoneum cancer | The University of Texas Health Science Center at San Antonio | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pegylated IFNα-2a | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01773889 ↗ |
| Route | Subcutaneous | “Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2A” NCT01773889 ↗ |